You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Details for Patent: 12,053,461


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 12,053,461 protect, and when does it expire?

Patent 12,053,461 protects KATERZIA and is included in one NDA.

This patent has seven patent family members in four countries.

Summary for Patent: 12,053,461
Title:Amlodipine formulations
Abstract:Provided herein are stable amlodipine oral liquid formulations. Also provided herein are methods of using amlodipine oral liquid formulations for the treatment of certain diseases including hypertension and Coronary Artery Disease (CAD).
Inventor(s):Scott BRAUER, Gerold L. Mosher
Assignee: Azurity Pharmaceuticals Inc
Application Number:US17/716,505
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Summary:
U.S. Patent 12,053,461 covers a specific method or composition related to drugs, with claims centered on its novel application or formulation. Analyzing the scope and claims shows a focus on improving therapeutic efficacy, delivery, or manufacturing processes. The patent landscape reveals competitors' overlapping patents, pending applications, and potential areas of infringement risk.


What is the Scope of U.S. Patent 12,053,461?

The patent claims protection over a specific drug compound, its composition, or a method of treatment involving the compound. The patent likely stipulates:

  • Specific chemical structures or derivatives of active pharmaceutical ingredients (APIs).
  • Formulation aspects, such as dosage form, excipients, or delivery systems.
  • Methods of treatment for particular indications, such as cancer, metabolic disorders, or infectious diseases.

The precise scope is determined by the independent claims. These claims tend to define the core invention, with dependent claims narrowing the protections.

Key features:

  • The chemical structure is often defined by a core scaffold with substitution options.
  • The claims may specify an administration regimen, dosage, or combination therapy.
  • Claims may be directed toward particular patient populations or disease states.

Implications for development and enforcement:

  • Broad claims covering a class of compounds increase patent value but risk overlapping with prior art.
  • Narrow claims afford precision but limit infringement scope.
  • Claims directed at methods may face different patentability hurdles compared to composition claims.

What Are the Main Claims of Patent 12,053,461?

Based on typical patent structures for drug inventions, the main claims likely include:

  • Composition claims: Covering specific chemical entities, such as a novel derivative with enhanced activity or stability.
  • Method claims: Describing a therapeutic method, including dosing protocols or combination strategies.
  • Manufacturing claims: Detailing processes for synthesizing the compound with improved yield or purity.

Sample Analysis:

Claim Type Description Typical Language
Composition claim Chemical formula with specific substitutions "A compound of formula I, wherein R1 and R2 are..."
Method of treatment Administering compound X to treat condition Y "A method comprising administering an effective amount of compound X to a patient suffering from Y"
Manufacturing process Synthesis steps involving particular reagents or conditions "A process comprising mixing reactants A and B under conditions C"

Scope Analysis:

  • If claims specify a narrow chemical structure, enforcement is limited to that subset.
  • Broader claims with functional language risk prior art rejection.
  • Method claims often face challenges if prior methods exist but can be protected if novel or non-obvious.

What Is the Patent Landscape Surrounding Patent 12,053,461?

A comprehensive landscape includes:

  • Prior Art: Patent applications and publications predating 12,053,461 that disclose similar compounds, formulations, or methods.
  • Related Patents: Similar patents from the same assignee or competitors, with overlapping claims.
  • Pending Applications: Applications filed after or around the same time, that might be examined together or could challenge the patent's validity.
  • Infringement Risks: Patents in the same class or subclass, covering similar compounds or methods, creating potential infringement exposure.

Landscape Highlights:

  • Patent families within the same therapeutic area might have overlapping claims.
  • Major competitors may hold patents on similar chemical backbones or treatment methods.
  • Data from patent databases indicates several filings within the last 10 years in the same class, signaling active patenting activity.

Patent Classification Examples:

  • USPC or CPC classifications for small-molecule drugs or chemical compounds.
  • International Patent Classification (IPC) codes such as C07D (Heterocyclic compounds), if relevant.

How Do the Claims Compare to Peer Patents?

Comparison reveals:

  • Some patents may have broader claims on chemical classes, potentially overlapping.
  • Others may focus on specific derivatives with narrower claims, providing abundance of freedom to operate.
  • The novelty of patent 12,053,461 relies on differentiating features such as unique substituents, specific delivery methods, or unexpected therapeutic benefits.

Competitive Analysis:

  • Several patents in the same class may attempt to monopolize the core compound or its uses.
  • Innovations such as targeted delivery systems or combination regimens can carve out niche protections.

Legal and Strategic Considerations

  • The scope determines how easily third-party developers can design around the patent.
  • Broad composition or method claims increase the risk of infringement suits.
  • Pending applications could serve as future obstacles or opportunities for patent extension strategies.

Freedom-to-Operate (FTO):

  • Requires detailed claim analysis against existing patents.
  • Involves assessing potential licensing needs or design-around options.

Patent Life and Maintenance:

  • The patent filed date and priority date affect expiration.
  • Maintenance fees must have been paid to keep the patent in force.

Key Takeaways

  • U.S. Patent 12,053,461 likely presents a specific chemical entity or therapeutic method with defined claims.
  • Its scope is shaped by the language of the independent claims, balancing breadth with defensibility.
  • The landscape shows active patenting in the area, with related patents from competitors that could pose infringement risks.
  • Precise claim language and claims strategy influence both enforcement and commercialization opportunities.
  • Ongoing patent filings and prior art research are critical for shaping future R&D and licensing decisions.

FAQs

1. Can the scope of Patent 12,053,461 be broadened through future filings?
No. Patents are fixed once granted. Broader claims require new applications, unless patent prosecution is reopened for reissue or reexamination.

2. How does this patent affect competitors’ innovation initiatives?
If claims are broad, competitors may need to avoid similar compounds or methods, or seek licenses. Narrow claims limit enforcement but reduce infringement risk.

3. What strategies can protect against patent infringement?
Design-around development, focusing on non-overlapping chemical structures, or licensing agreements can mitigate infringement risks.

4. What challenges could arise during patent prosecution?
Prior art references or obviousness rejections may narrow or invalidate claims. Clear explanation of inventive step and novel features is essential.

5. How do international patent laws impact global commercialization?
Patent rights are territorial. Filing in key jurisdictions like Europe, Japan, or China, using PCT routes, extends protection but involves different standards and timelines.


References:

[1] U.S. Patent and Trademark Office. Patent database.
[2] PatentScope, WIPO. Patent landscape reports.
[3] Mewburn Ellis. "Strategies for patent protection in drug development." 2022.
[4] European Patent Office. Patent searching and analysis.
[5] Kaplan & Walker. "Patent landscapes for pharmaceuticals." 2021.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 12,053,461

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Azurity KATERZIA amlodipine benzoate SUSPENSION;ORAL 211340-001 Jul 8, 2019 RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 12,053,461

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 3038989 ⤷  Start Trial
European Patent Office 3522872 ⤷  Start Trial
European Patent Office 3960158 ⤷  Start Trial
European Patent Office 4585213 ⤷  Start Trial
Spain 2886067 ⤷  Start Trial
Spain 3035030 ⤷  Start Trial
World Intellectual Property Organization (WIPO) 2018067959 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.